Group 1 - Shenzhen Kangtai Health Medical Technology Co., Ltd. has received approval from the National Equities Exchange and Quotations (NEEQ) for its stock to be publicly transferred and listed on the National SME Share Transfer System, with a stock code of 874918.NQ [1][9] - The company specializes in the research, production, and sales of customized dental medical devices, serving both domestic and international dental service institutions and denture manufacturers [5][13] - Kangtai's listing journey began in mid-2023, with the company submitting its public transfer application and disclosure documents on June 27, 2023, and receiving approval in less than three months [7][9] Group 2 - Kangtai's projected revenue for 2023 and 2024 is 391 million yuan and 470 million yuan, respectively, indicating a steady growth trend, while net profits are expected to be 41.9 million yuan and 50.9 million yuan [10][12] - The company has shown resilience in a challenging market environment, with the dental industry facing significant challenges, including a high number of dental service institutions exiting the market [13][18] - Kangtai's focus on innovation and technology has been recognized through various awards, indicating its commitment to research and development, which is crucial for maintaining competitiveness in the dental medical device industry [17][18]